Algorae Pharmaceuticals LimitedASX: 1AI

Change of Director's Interest Notice - DH, DG, TV

· Issued by Algorae Pharmaceuticals Limited via ASX

Filed with ASX · · 11 pages · English

Summary by 6ix AI

The notice outlines the number of securities held before and after the changes, including performance rights and options. It specifies the nature of the changes, which include the issuance of performance rights following shareholder approval at a recent annual general meeting. The document serves to inform the ASX and the public about the directors' interests in the company's securities as required by regulations.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced...

Algorae Pharmaceuticals Limited on 6ix

Earlier from Algorae Pharmaceuticals

Later from Algorae Pharmaceuticals

All Algorae Pharmaceuticals news releases